Navigation Links
Specialized Care for Ovarian Cancer Improves Outcomes

Dutch study cites better survival rates, but one expert urges caution

TUESDAY, March 11 (HealthDay News) -- Treatment at semi-specialized or specialized hospitals improved survival time for ovarian cancer patients, a Dutch study found.

For the study, the researchers examined data on 8,621 ovarian cancer patients treated in the Netherlands between 1996 and 2003. Of those women, 40 percent were treated in general hospitals, 41 percent in semi-specialized hospitals, and 18 percent in specialized hospitals. Five-year survival was 38 percent, 39.4 percent, and 40.3 percent, respectively.

The University Medical Center Utrecht researchers said the difference was statistically significant for women ages 50 to 75 who were diagnosed with early ovarian cancer. Their risk of death decreased by 30 percent (semi-specialized hospital) and 42 percent (specialized hospital), compared to those treated at a general hospital.

"This result indicates that the level of collaboration during the study period did not suffice to deliver optimal care to all Dutch ovarian cancer patients, and regionalization of the care for such patients thus seems necessary," the researchers wrote.

The study was published online March 11 in the Journal of the National Cancer Institute.

While this and other studies that correlate patterns of care and clinical outcomes are important, they need to be interpreted with caution, Dr. Deborah Schrag, of the Dana-Farber Cancer Institute in Boston, wrote in an accompanying editorial. Confounding variables and information that isn't tracked in such studies can lead to inaccurate conclusions, she warned.

For example, in the Dutch study, the ages and types of treatment received by ovarian cancer patients at general hospitals appeared to be different than those of patients treated at semi-specialized and specialized hospitals. In addition, there was no information about other health issues that may have affected patient results.

"Therefore, this analysis, in and of itself, does not justify regionalization of ovarian cancer surgery in the Netherlands to specialty centers," Schrag wrote.

In order to achieve more accurate analyses, cancer registries need to collect a wider range of information, she suggested.

"As the number of cancer therapies increases, and as the need to systematically evaluate their real-world clinical effectiveness grows, there is a need to optimize the data that can be gleaned from observational data sources," Schrag wrote. "A compelling case can be made for expanding the scope of data that tumor registries collect."

More information

The American Cancer Society has more about ovarian cancer treatment.

-- Robert Preidt

SOURCE: Journal of the National Cancer Institute, news release, March 11, 2008

Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Specialized Care Essential for Women With Congenital Heart Disease Undergoing Pregnancy
2. Specialized System Speeds Heart Attack Treatment
3. Medcos Specialized Pharmacists, Safety Programs Gain Therapy Management Accreditation
4. Those With Disabilities as Well as Aging Population Throughout Country Now Have Access to Thousands of Specialized Products
5. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
6. Recurrent low-grade carcinoma of the ovary less responsive to chemo than more common ovarian cancers
7. Advanced-stage ovarian cancer patients with BRCA live longer, may respond better to treatment
8. Gleevec May Disrupt Ovarian Function
9. U of Minnesota study finds thalidomide shows promise for treatment of recurrent ovarian cancer
10. Researchers identify and shut down protein that fuels ovarian cancer
11. Combo Treatment Best for Melanoma, Advanced Ovarian Cancer
Post Your Comments:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: